323 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
LGND Ligand Pharmaceuticals Incorporated $253.56 $5.35B N/A
Article Searches
AMAG Q4 Loss Narrower Than Expected, Revenues Lag Estimates http://www.zacks.com/stock/news/353350/amag-q4-loss-narrower-than-expected-revenues-lag-estimates?cid=CS-ZC-FT-353350 Feb 08, 2019 - AMAG encourages with narrower-than-expected loss in Q4 while revenues fall shy of estimates.
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4239317-ligand-pharmaceuticals-incorporated-lgnd-ceo-john-higgins-q4-2018-results-earnings-call?source=feed_sector_healthcare Feb 08, 2019 - Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2018 Results Earnings Conference Call February 07, 2019, 04:30 PM ET Company Participants Todd Pettingill - Director, Corporate Development and Inv
Vertex (VRTX) Q4 Earnings Beat on Solid CF Products Sales http://www.zacks.com/stock/news/352543/vertex-vrtx-q4-earnings-beat-on-solid-cf-products-sales?cid=CS-ZC-FT-352543 Feb 06, 2019 - Vertex's (VRTX) Q4 grows on earnings and revenue beat with rising demand for its CF products. Shares up.
Looking For Entry After Apricus And Seelos 'SEEL' The Deal https://seekingalpha.com/article/4236123-looking-entry-apricus-seelos-seel-deal?source=feed_sector_healthcare Jan 28, 2019 -
Ligand: Interesting Pharma Play On Sale https://seekingalpha.com/article/4231581-ligand-interesting-pharma-play-sale?source=feed_sector_healthcare Jan 05, 2019 - Ligand Pharmaceuticals is an interesting and diverse play on growth of the pharmaceutical industry.I like the interesting business model, as Ligand appears to have a very rich pipeline.A very strong m
Ligand: A Highly Diversified Innovator Positioned For Success https://seekingalpha.com/article/4231536-ligand-highly-diversified-innovator-positioned-success?source=feed_sector_healthcare Jan 04, 2019 - Amid the current bear market, many fundamentally sound companies are on sale at a deep bargain. Hence, we are continually on the hunt for high-quality stocks.Ligand Pharmaceuticals is an excellent bar
Viking Therapeutics Won't Live Up To The Hype https://seekingalpha.com/article/4222613-viking-therapeutics-live-hype?source=feed_all_articles Nov 26, 2018 - VK-2809 has neither clinical data nor an IND in NASH and its development lags 2.5 - 3 years behind MGL-3196.Even if successful in a NASH trial, VK-2809 will be competing in a crowded space with variou
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4220007-ligand-pharmaceuticals-incorporated-lgnd-ceo-john-higgins-q3-2018-results-earnings-call?source=feed_sector_healthcare Nov 08, 2018 - Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2018 Earnings Conference Call November 08, 2018 09:00 AM ET Executives Todd Pettingill - Director, Corporate Development and Investor Relations Joh
Ligand Pharmaceuticals (LGND) Tops Q3 Earnings and Revenue Estimates http://www.zacks.com/stock/news/336302/ligand-pharmaceuticals-lgnd-tops-q3-earnings-and-revenue-estimates?cid=CS-ZC-FT-336302 Nov 08, 2018 - Ligand (LGND) delivered earnings and revenue surprises of 33.33% and 7.22%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What Lies in Store for Ligand (LGND) This Earnings Season? http://www.zacks.com/stock/news/335584/what-lies-in-store-for-ligand-lgnd-this-earnings-season?cid=CS-ZC-FT-335584 Nov 06, 2018 - Ligand's (LGND) partnered programs - Kyprolis and Promacta - using its Captisol formulation technology are expected to drive milestone and royalty payments in third-quarter 2018.

Pages: 123456...33

Page 1>

Related Companies

Name Exchange Price Mkt Cap
UTHR United Therapeutics Corporation NASDAQ $125.98 $5.49B
FGEN FibroGen, Inc NASDAQ $56.85 $4.79B
RDY Dr. Reddy's Laboratories Ltd NYSE $35.7 $5.93B
GLPG Galapagos NV NASDAQ $115.62 $5.94B
LOXO Loxo Oncology, Inc. NASDAQ $155.495 $4.74B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Ligand Pharmaceuticals Incorporated
LGND - Google Finance https://www.google.com/finance?q=LGND Industry related info and international coverage Summary News
LGND - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=LGND Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options